March 24, 2023 - Year in Review Report Now Available and more news…

Published: 24 March 2023

March 24, 2023

Foundation’s 2022 Year in Review Report Now Available

See focused ultrasound milestones and highlights from the Foundation’s accomplishments over the past year.
The report highlights global research breakthroughs, commercialization trends, and more.
Learn how you can support our efforts to advance focused ultrasound and impact the lives of countless patients worldwide.

Read the Report

Virginia Governor Glenn Youngkin Visits the Foundation

Governor Youngkin learned about focused ultrasound and how Virginia is advancing the field.
The University of Virginia and Virginia Tech are leading the state in research for a variety of disorders and veterinary applications.

Moving Cells with Focused Ultrasound

Caltech researchers have published a study using focused ultrasound to manipulate genetically engineered cells.
This technique could be useful for many applications in biomedical research and medicine, including cell sorting, tissue engineering, or cellular-based therapies.

NaviFUS Provides Research Update on GBM and Epilepsy

The Foundation recently hosted a live virtual event featuring Taiwan-based NaviFUS Corporation.
NaviFUS’ innovative devices are in clinical trials to address glioblastoma and epilepsy.
The company’s CEO Arthur Lung, PhD, and two physicians leading the clinical trials presented during the event.

Company Profile: Sinoways

Zhonghui Medical Technology Co., Ltd, or Sinoways, is a focused ultrasound company based in Shanghai, China.
The company is developing and testing a focused ultrasound device for the noninvasive treatment of uterine fibroids.
This profile is available in both traditional and simplified Chinese.

Read the Profile

Forwarded this email by a friend? Sign up to receive these emails here.

“We have established the fundamental capability to use ultrasound to physically direct specific cells to specific locations. In the future, this approach could potentially be used to guide a cell therapy to a tumor...”

‒ Mikhail Shapiro, PhD, Caltech

Do you have news for our newsletter? Tell us about it!